
Kindred Ventures has attracted university endowments for its second fund, building on the successes of its $56m debut vehicle launched just two years ago.
Advancing technology originating at UC Berkeley, Databricks has increased its valuation more than fourfold to $28bn and will use the funding to further scale its business.
Volpara Health has acquired CRA Health, a spinout of Havard Medical School’s teaching hospital Massachusetts General Hospital.
The firm announced its second fund the same day as one of its portfolio companies, University of Wyoming-backed Momentus, successfully listed on Nasdaq.
Harvard-linked Sana Biotechnology will raise as much as $397m if it floats at the upper end and underwriters take up the greenshoe option.
SR One reinvested in a series B round for the degenerative disorder drug developer that was led by venture fund Logos Capital.
Georgia Tech-linked battery technology producer Sila Nanotechnologies has more than tripled its valuation to $3.3bn in the series F round.
GV and Novartis Venture Fund joined 6 Dimensions Capital in a round that brought Harvard’s oncology drug developer's overall funding to $160m.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
The firm, which specialises in commercialising public and corporate research, has closed its largest fund to date.